approval
saveHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
community read0 votes
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalOct 16, 2025 · 400d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 29, 2025 · 479d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMay 20, 2025 · 549d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJun 12, 2024 · 891d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalSep 8, 2023 · 1169d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 14, 2023 · 1316d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMar 20, 2023 · 1341d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 18, 2022 · 1586d ago
same company · ±60 days · 6
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 19, 2024
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 19, 2024
- approvalJUBBONTI: JUBBONTI (DENOSUMAB-BBDZ) — FDA approvalMar 5, 2024
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalMay 7, 2024
- approvalondansetron ODT: ONDANSETRON — FDA approvalMay 31, 2024
- approvalondansetron ODT: ONDANSETRON — FDA approvalMay 31, 2024
comments(0)
5-min edit window · permanent after that